Thrombophilic conditions in non-cirrhotic portal vein thrombosis

Indian Journal of Gastroenterology

Volumn 24, Issue 5, 2005, Pages 205-210

  Shah, Sudeep R ^a   DasGupta, A ^a   Sharma, A ^a   Joshi, Anand ^a   Desai, Devendra ^a   Abraham, Philip ^b   Rathi, Pravin ^b   Bapat, Mukta ^b  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

^b KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTHROPLASTY; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENE MUTATION; HUMAN; LEG; LIVER CIRRHOSIS; LIVER FUNCTION; PORTAL VEIN THROMBOSIS; PREVALENCE; SCHOOL CHILD; THROMBOPHILIA; CHILD; FEMALE; MIDDLE AGED; PATHOPHYSIOLOGY; PORTAL VEIN; PROSPECTIVE STUDY; VEIN THROMBOSIS;

ADOLESCENT; CHILD; FEMALE; HUMANS; MIDDLE AGED; PORTAL VEIN; PROSPECTIVE STUDIES; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 33644796365     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-73.
2. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32:865-71.
3. Shah SR, Desai CS, Mathur SK. Incidence and fate of antral varices. Eur J Gastroenterol Hepatol 1999;11:1041-3.
4. Koshy A, Bhasin DK, Kapur KK. Bleeding in extrahepatic portal vein obstruction. Indian J Gastroenterol 1984;3:13-4.
5. Webb LJ, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med 1979;48:627-39.
6. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al . Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-91.
7. Pabinger I, Allaart CF, Hermans J, Briet E, Bertina RM. Hereditary protein C deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC Subcommittee on Protein C and Protein S. Protein C Transmitter Study Group. Thromb Haemost 1992;68:470-4.
8. Wolf M, Boyer-Neumann C, Peynaud-Debayle E, Marfaing-Koka A, Amiral J, Meyer D. Clinical applications of a direct assay of free protein S antigen using monoclonal antibodies. A study of 59 cases. Blood Coagul Fibrinolysis 1994;5:187-92.
9. Abildgaard U, Lie M, Odegaard OR. Antithrombin (heparin cofactor) assay with new chromogenic substrate (S-2238 and chromozym TH). Thromb Res 1977;11:549-53.
10. Hardisty RM, Macpherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh 1962;7:215-28.
11. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986;68:869-74.
12. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995;41:991-4.
13. Luzzato l, Hillmen P. Laboratory methods used in the investigation of PNH. In: Dacie TV, Lewis SM, Eds. Practical Hematology. Edinburgh: Churchill Livingstone. 1994: p. 289-92.
14. Bradley GM, Benson ES. Examination of the urine. In: Davidson I, Henry JB, Eds. Todd-Sanford Clinical Diagnosis by Laboratory Methods. Philadelphia: W B Saunders. 1974: p. 38.
15. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, Breda-Vriesman PJ, et al . Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
16. Harris EN, Gharavi AE, Patel SP, Hughes GR. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
18. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ , de Ronde H, et al . Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
19. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
20. Denninger MH, Helley D, Valla D, Guillin MC. Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis. Thromb Haemost 1997;78:1297-8.
21. Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak-Gottl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999;19:2568-72.
22. Hertzberg MS, Underwood T, Favaloro EJ. Mesenteric vein thrombosis secondary to combined protein C deficiency and double heterozygosity for factor V Leiden and prothrombin G20210A. Am J Hematol 1999;62:199-200.
23. Mainwaring CJ, Makris M, Thomas WE, Hampton KK, Preston FE. Mesenteric infarction due to combined protein C deficiency and prothrombin 20210 defects. Postgrad Med J 1999;75:742-3.
24. Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997;40:798-800.
25. Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A, et al . Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost 2001;7:158-65.
26. Gou D, Naipal A, Reitsma PH. World distribution of factor V Leiden mutation. Lancet 1996;347:59.
27. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from western India. Hepatology 2001;34:666-70.
28. Yachha SK, Aggarwal R, Sharma BC, Misra RN, Aggarwal A, Naik SR. Functional protein C and anti-cardiolipin antibody in children with portal vein thrombosis. Indian J Gastroenterol 2001;20:47-9.
29. Ahuja V, Marwaha N, Chawla Y, Dilawari JB. Coagulation abnormalities in idiopathic portal venous thrombosis. J Gastroenterol Hepatol 1999;14:1210-1.
30. Ahuja V, Chawla Y, Marwaha N, Dilawari J. Two patients with portal vein thrombosis from lupus anticoagulant. J Clin Gastroenterol 1998;26:352-3.
31. Mack CL, Superina RA, Whittington PF. Surgical restoration of portal flow corrects procoagulant and anticoagulant deficiencies asociated with extrahepatic portal vein thrombosis. J Pediatr 2003;142:197-9.
32. Dubuisson C, Boyer-Neumann C, Wolf M, Meyer D, Bernard O. Protein C, protein S and antithrombin III in children with portal vein obstruction. J Hepatol 1997;27:132-5.
33. Fisher NC, Wilde JT, Roper J, Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut 2000;46:534-9.
34. Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, et al . Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001;120:490-7.